ZeroStack Corp.
NASDAQCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Daniel Reis-Faria
- Full Time Employees
- 21
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Address
- 40 King Street West Toronto ON Canada M5H 3Y2
- IPO Date
- May 11, 2021
- CIK
- 0001790169
- Website
- zerostack.ai
- Similar Companies
- Business
- ZeroStack Corp. operates as an AI-focused asset management and technology solutions company, delivering decentralized AI exposure through an integrated platform and related services. The company combines AI-driven investment strategies with digital asset initiatives and healthcare distributions through its subsidiary framework, aligning software-enabled asset management with operational execution across multiple sectors. Main products and services - AI-enabled asset management platform: decentralized AI investment exposure via a software-driven, digital-asset framework; governance and yield generation through staking, validators, and ecosystem participation - Digital asset and token-based programs: native digital assets and blockchain-enabled products designed to complement AI investment strategies; exposure generation through tokenized ecosystems - Pharmaceutical distribution and wholesale: Phatebo GmbH and related subsidiaries handle global pharmaceutical distribution, logistics, and regulatory-compliant operations - Healthcare and life sciences services: AI-enhanced supply chain optimization, regulatory compliance, and related services for healthcare stakeholders - Broad commercial and wholesale operations: distribution of pharmaceutical products and ancillary items across multiple categories, including wellness and technology-related products Latest major company changes - Strategic pivot to AI-focused asset management and branding refresh to reflect emphasis on decentralized AI and related services; expansion into AI-driven financial exposure and digital-asset strategies - Expansion of European pharmaceutical distribution capabilities via Phatebo GmbH, including new high-value orders and expanded regulatory-compliant logistics operations in key European markets - Strategic partnerships and alliances enhancing cloud and AI capabilities, including collaboration with public cloud ecosystems to streamline hybrid cloud management and operational efficiency - New product and service launches in AI-enabled asset management and pharmaceutical distribution, with ongoing efforts to broaden the company’s addressable markets and geographic reach - Corporate reorganizations and governance updates aligned with the expanded portfolio, including enhancements to compliance, oversight, and international operations Industry and business segments - AI and digital assets: decentralized AI investment exposure, AI-powered asset management, digital asset strategies - Healthcare and pharmaceuticals: wholesale distribution, regulatory-compliant logistics, and healthcare ecosystem services - Cloud and IT infrastructure: hybrid cloud platform capabilities, public-private cloud integration, and managed cloud services through strategic technology partnerships - Global operations: head office and primary activities concentrated in North America with distributed operations in Europe and other regions through subsidiaries Target markets and customers - Institutional investors and asset managers seeking AI-driven exposure and yield-generation opportunities - Healthcare providers, hospitals, distributors, and pharmaceutical manufacturers requiring AI-assisted supply chain optimization and compliant distribution - Enterprises seeking hybrid cloud solutions and integrated AI-enabled cloud platforms for private and public cloud management Founding year and headquarters - Founding year: 2019 - Headquarters: Paris, Île-de-France, France Subsidiaries and parent relationships - Phatebo GmbH and TruHC as subsidiaries involved in pharmaceutical distribution and related wholesale activities - Corporate structure encompassing AI-focused asset management with ancillary healthcare and technology service arms Notes - The company positions itself at the intersection of AI-driven asset management and healthcare distribution, pursuing growth through both financial technology initiatives and expanded operational capabilities in Europe and beyond. The latest activity emphasizes strategic alliances, product launches in AI and cloud platforms, and scaling pharmaceutical distribution through its European subsidiary network.
ZeroStack Announces Results of 2026 Annual and Special Meeting of Shareholders, Provides Phatebo Purchase Orders Update and Announces Closing of Previously Announced Cryptocurrency Financing
ZeroStack Corp. Secures Purchase Orders for up to US$14.7 Million of Inventory from Two Pharmaceutical Companies
DeFi Dev Corp. Announces Strategic Leadership Transition of DisclaimerCoin (DONT) to Dedicated Ecosystem Team
Nasdaq-Listed ZeroStack Corp. Makes $107 Million Institutional Commitment To Increase Strategic Position in 0G Token Ecosystem
ZeroStack Announces $107 Million Cryptocurrency Financing, Elimination of Convertible Note and Plan to Redomicile to Texas
ZeroStack Corp. Reports 3.2 Million 0G Tokens Earned in Staking Rewards at 22% APY
ZeroStack Corp. Secures $6.5 Million Order from Major Pharmaceutical Company to Support Distribution in Germany
ZeroStack Corp. Reports First One Million in 0G Token Staking Rewards at 21% APY
Flora Growth Corp. Announces Withdrawal of Proposed Public Offering
Flora Growth Corp. Announces Proposed Underwritten Public Offering
Flora Growth Corp. Announces Name Change to ZeroStack Corp., Furthering Its Strategy as an AI-Focused Asset Management Company
Flora Growth Announces Results of 2025 Special Meeting of Shareholders
Why Did Flora Growth Corp (FLGC) Surge 6% In After-Hours Trading?
Flora Growth Corp. (FLGC) Reports Q3 Loss, Misses Revenue Estimates
Flora Growth Corp. Announces Second Purchase of 0G, the Fuel of the 0G Decentralized AI Network
Flora Growth Corp. Appoints BitGo as Custodian for $0G Treasury
Flora Growth Corp. Announces First Purchase of 0G, the Fuel of the 0G Decentralized AI Network
Flora Growth Corp. (FLGC) Announces $401 Million Funding with a $22.88 Million Strategic Investment from Defi Development Corp. (DFDV) to Initiate Groundbreaking AI Zero Gravity ($0G) Coin Treasury Strategy
Flora Regains Compliance with NASDAQ Minimum Bid Requirement
Flora Growth Corp. (FLGC) Reports Q2 Loss, Tops Revenue Estimates